Apply for 2022 intake

SPOTLIGHT

Duke-NUS and Lion TCR ink exclusive IP licensing agreement for immunosuppressive drug-resistant anti-cancer T-cells

Events

25 Jun 2021

[GH Seminar Series] Mapping the dynamics of prevention and management of non-communicable diseases in Cambodia

29 Jun 2021

Signature Seminar Series (Virtual): Lipid Peroxidation, Lipohormesis And Lipotoxicity In Pancreatic Beta Cells

30 Jun 2021

CARE's Research Methods Workshop: Understanding and Using Decision Analysis

02 Jul 2021

[EID Virtual Seminar] - STRUCTURE BASED DEVELOPMENT OF DENGUE VACCINE

07 Jul 2021

2021 DIA-CoRE Singapore Annual Meeting (Virtual Meeting)

View all events

NEWS

22 Jun 2021

Duke-NUS and GenScript announce notice of allowance for U.S. patent application for SARS-CoV-2 surrogate virus neutralisation test

(New Jersey, US/Singapore, 21 June 2021) GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leadi...

18 Jun 2021

Blocking IL-11 signalling can help liver regenerate after injury from paracetamol toxicity

A signalling protein thought to be able to treat liver damage in paracetamol toxicity could actually worsen it. Instead,...

16 Jun 2021

Close-up look at brain uptake of omega-3

Cryo-electron microscopy and computer simulations uncover how a cellular protein helps transport omega-3 fatty acids to ...

View all news

Dr Kaavya Narasimhalu

Clinical Assistant Professor
(Class of 2012)

Duke-NUS has given me the flexibility to manage research and clinical medicine. It also has an outstanding clinical faculty that insists that we gain essential clinical skills despite having a shorter time in which to do so. Without the clinical faculty, I would never have made it this far.